ABPRX
Price
$88.90
Change
-$2.00 (-2.20%)
Updated
Feb 21 closing price
Net Assets
27.8B
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

ABPRX vs GFACX

Header iconABPRX vs GFACX Comparison
Open Charts ABPRX vs GFACXBanner chart's image
AB Large Cap Growth R
Price$88.90
Change-$2.00 (-2.20%)
VolumeN/A
Net Assets27.8B
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
ABPRX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABPRX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABPRX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. ABPRX (27.8B). ABPRX (0.00) and GFACX (0.00) have matching dividends . ABPRX was incepted earlier than GFACX: ABPRX (21 years) vs GFACX (24 years). ABPRX is a more actively managed with annual turnover of: 38.00 vs. GFACX (31.00). ABPRX has a lower initial minimum investment than GFACX: ABPRX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 10.15 vs. ABPRX (5.92). ABPRX return over 5 years is better than : 55.26 vs. GFACX (32.83).
ABPRXGFACXABPRX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years24 years-
Gain YTD1.3112.98044%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets27.8B304B9%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.9210.1558%
Returns for 3 years28.3017.69160%
Returns for 5 years55.2632.83168%
Returns for 10 years130.1955.63234%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding